Evaluation of Phase 1 GAVI Immunization Services Support (ISS) Funding

Slides:



Advertisements
Similar presentations
Synergies between the GAVI Alliance and health systems strengthening Dr. Craig Burgess, GAVI Secretariat 29 May 2008.
Advertisements

Global Alliance for Vaccines and Immunization. n An Alliance u Traditional and new partners u Public and private sector n Partners have in common: u Situation.
GAVI Support and the Health Information System
Development Policy Lending Retrospective Customization, Flexibility, and Results OPCS, Country Economics.
Measuring the Impact: Cross-Country Quantitative Analysis.
Global Alliance for Vaccines and Immunization. WHAT IS GAVI ?
1 Assessment of Cambodia’s Statistics Capacity Prepared by Zia A. Abbasi IMF Multi-sector Statistics Advisor, Cambodia for the International Conference.
Critical conversations in Public-private partnerships Dr Ranjana Kumar 1 st November 2007.
Economic Growth in Mozambique Experience & Policy Challenges Crispolti, V. (AFR) Vitek, F. (SPR)
1 European Region Global Alliance for Vaccines & Immunization Overview on the Implementation Of the Introduction of New / Under-used Vaccines.
Peter Hansen Perspectives on Performance Based Financing within the GAVI Alliance Clermont-Ferrand, 11 May 2011.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Impacts of high and volatile oil prices and policy choices Shikha Jha.
Increasing transparency and social expenditure in public budgets Iván Fernández Espinoza Technical Secretary of the Social Front Quito-Ecuador.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
UN-Water Water Country Briefs Introduction & Background Frederik Pischke Interagency Water Advisory UN-Water Frederik Pischke Interagency Water Advisory.
Basic facts about the GAVI Alliance Speaker
HIV and AIDS Data Hub for Asia-Pacific Review in slides Bhutan.
Monitoring health systems Health system metrics Health Metrics Network 1 st Steering Committee Meeting March
Warsaw, Poland May 17, 2010 Poland Social Sector and Public Wages Public Expenditure Review From Maastricht to Vision 2030 Overview.
ALLIE BAGNALL DANIEL BELLEFLEUR MARISSA MOMMAERTS EMILY PLAGMAN Evaluation of the U.S. Government Millennium Challenge Corporation “Investing In People”
Countdown to 2015: Tracking Progress in Child Survival. London, December Thinking Big: Going into Action for Child Survival Sustainable Financing.
Performances Based Financing scheme in Rwanda INVESTING MORE STRATEGICALLY 1.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
Country Report Progress Toward Strengthening EPI [Country Name]
1. 2 Introduction Purpose of the ICP UN System of National Accounts calls for comparisons of GDP across countries be using PPPs The Approach Collection.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Papua New Guinea Last updated: July 2015.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
AMC Governance and Institutional Support. Objectives Build on existing capacity Ensure appropriate independence and credibility through transparency,
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
T h e A A A H Asia-Pacific Action Alliance on Human Resources for Health.
Dollarization in ecuador
Performance Audit The GAVI Alliance Data Quality Audit experience May 2008 ICGFM conference Dr. Mercy Ahun GAVI Alliance Secretariat, Geneva.
Interactions between health systems and Global Health Initiatives – what we learnt to inform research methodology Joseph Perriëns on behalf of Badara Samb.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar.
Anatomy of PforR Alan Gelb and Nabil Hashmi Center for Global Development January 23, 2014 PforR Presentation a
Gavi’s Measles and Rubella Programme:Update Stefano Malvolti September 2015, Washington DC Page: 1 Reach every child.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Lao PDR Last updated: July 2015.
Is Performance-Based Reward the Strategy of the Future for Strengthening the Quality of Reporting and Immunization Systems?—Experiences from GAVI Trap,
Remittances and Human Capital Investment: Evidence from Albania Ermira Hoxha Kalaj December 2010.
1 January 2005 Introduction to Phase 2 and General Update Lesotho CCM.
Women, Work, and the Economy: Macroeconomic Gains from Gender Equity The views expressed in this presentation are those of the authors and should not be.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste.
BASIC FACTS ABOUT GAVI, THE VACCINE ALLIANCE Page: 1 #vaccineswork Gavi/2012/Doune Porter.
Global Programme Framework Document Tiina Vähänen, UN-REDD Programme Secretariat.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
Measles Rubella Meeting
Njeri Kariuki United Nations Forum on Forests
Dictatorship, Patronage and Public Good Provision
From universal access to universal coverage
Mongolia Last updated: April 2016.
Development and Growth in Mineral-Rich Countries
Pakistan Last updated: July 2015.
World Health Organization
World Health Organization
Gavi’s Measles and Rubella Programme
China 2010 UNGASS Country Progress Report
National accounts and SDGs
Effects of Aid on Recipients: Sectoral Approach
Papua New Guinea.
New East Asian Alliances
Immunizations for Young Children
HEALTH AID, GOVERNANCE AND INFANT MORTALITY
Papua New Guinea.
Global Health Exchange Conference, Dublin – 6 November 2018
By Michael Mbate UN Economic Commission for Africa
Review in slides Lao PDR
Developing a Financial Sustainability Plan for Cambodia
Presentation transcript:

Evaluation of Phase 1 GAVI Immunization Services Support (ISS) Funding Grace Chee, Natasha Hsi Kenneth Carlson, Slavea Chankova, Patricia Taylor

GAVI Alliance Formerly known as the Global Alliance for Vaccines and Immunization Provides support to Governments for: New vaccines Injection safety Immunization Support Services Health System Support Civil Society Support

Immunization Services Support Performance-based funding given to governments Flexible funding to be used for strengthening immunization services Funding comprised of an investment share and a reward share Reward share contingent on increasing the number of children immunized and passing a Data Quality Audit (DQA)

Areas of Evaluation Experience of the ISS scheme Impact of ISS on overall immunization financing Impact of ISS on immunization program performance Factors correlated with differences in performance Impact of ISS design and structure on immunization performance

Evaluation Methods Regression model with data from 52 countries that received ISS funding by Dec 2005 In-depth comparative study of three pairs of GAVI-recipient countries

Data for Regression Model Data from 52 countries that received ISS funding by Dec 2005 Relies on Annual Progress Reports, WHO-UNICEF JRFs, FSPs (29) Disbursement data from GAVI Secretariat WHO-UNICEF Best Estimates of DTP3 coverage rates WHO & World Bank data on economic, health expenditure, and political indicators

Modeling Methods Builds on regression model developed by Lu et al. to test effects of ISS expenditures on DTP3 coverage rates Model consisted of ISS expenditures, WHO-UNICEF Best Estimates DTP3 coverage rate, and covariates Covariates: GDP per capita, IBRD Political Stability Index, average DTP3 coverage rate 1998-2000 Tested for effects of ISS expenditures using the logistic transformation of DTP3 coverage rates as the dependent variable

In-depth Country Studies Studied three pairs of countries with similar characteristics at beginning of GAVI, but different outcomes Cambodia Laos PDR Tanzania Zambia DRC Guinea DTP3 at baseline (application 65% 56% 74% 75% 31% 57% DTP3 in 2005 82% 49% 90% 80% 73% 69% LICUS status Yes No Political stability index in 2000 -0.93 -0.27 -0.52 -0.73 -2.93 -1.44 Political stability index in 2005 0.29 -0.11 -0.37 0.02 0.23 DQA verification factor 98% 59% 79% 88% 95%

Qualitative Questions for In-depth Country Case Studies How has ISS been integrated into health system planning? What are factors that foster or constrain improvements? How does flexibility of ISS funding affect performance? How do rewards affect coverage? What do countries do when they fail their DQA?

Findings and Results Evaluation concluded Sep 07, and findings submitted to GAVI Findings to be released by GAVI in the next month should be available on GAVI website www.gavialliance.org findings and recommendations will be considered in future GAVI policies

Thank you